Investor mix
16 investors on record; lead investors include Cell Innovation Partners, HEDA Ventures, Lilly Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 56% |
| Private equity | 1 | 6% |
| Accelerator & incubator | 3 | 19% |
| Other / undisclosed | 3 | 19% |
Developer of compounds to protect against tissue degradation and promote healing during illness or injury
16 investors on record; lead investors include Cell Innovation Partners, HEDA Ventures, Lilly Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 56% |
| Private equity | 1 | 6% |
| Accelerator & incubator | 3 | 19% |
| Other / undisclosed | 3 | 19% |